title: Pricing for orphan drugs: will the market bear what society cannot?
authors.affiliation: Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01655, USA. osullivb@ummhc.org
authors.forename: Brian P
authors.initials: BP
authors.lastname: O'Sullivan
authors.forename: David M
authors.initials: DM
authors.lastname: Orenstein
authors.forename: Carlos E
authors.initials: CE
authors.lastname: Milla
mesh_terms: D000627:Aminophenols / Q000191:economics / Q000627:therapeutic use; D017047:Cost Sharing; D003550:Cystic Fibrosis / Q000188:drug therapy; D016527:Drug Costs; D055808:Drug Discovery; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D005102:Health Expenditures; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics*; D015363:Quinolones / Q000191:economics / Q000627:therapeutic use; D012935:Social Justice; D014481:United States
chemical_list: D000627:Aminophenols; D015363:Quinolones; C545203:ivacaftor